Pre-Clinical Development      CMC      Clinical Development & Regulation      Intellectual property      Publication
Intellectual property
ITabMed protects its intellectual property rigorously. By collaborating with well-known law firms at domestic and overseas, ITabMed has established a complete IP system to manage IP portfolios, IP risk mitigation and IP licensing in/out.

As of now, ITabMed has filed 29 patents worldwide in accordance with business strategy. ITabMed’s patent portfolio protects its IP positions in China, USA, Europe, Japan, and other major markets. The iTAb technology platform patents have been granted in China, USA, and Japan.

The intellectual property is a very important part of ITabMed to create value. The company is committed to further strengthen and broaden its IP portfolios.

Copyright © 2021 ITabMed Co., Ltd. All Rights Reserved